Cross John Harry III 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Apr 8, 2022
Insider Transaction Report
Form 4
Cross John Harry III
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-15+66,951→ 145,165 total
Footnotes (2)
- [F1]On December 15, 2021, the Reporting Person was granted 66,951 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
- [F2]Includes unvested RSUs.